The generation of 3-D tissue models based on hyaluronan hydrogel-coated microcarriers within a rotating wall vessel bioreactor

Biomaterials

Volumn 31, Issue 32, 2010, Pages 8426-8435

  Skardal, Aleksander ^a,b   Sarker, Shameema F ^c   Crabbé, Aurélie ^c   Nickerson, Cheryl A ^c   Prestwich, Glenn D ^a,b  

^a Department of Electrical and Computer Engineering   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c Arizona State University   (United States)

Author keywords

3 D Cell aggregates; Hyaluronic acid; Low fluid shear stress; Microcarrriers; Synthetic extracellular matrix; Thiol disulfide exchange reaction

Indexed keywords

CELL AGGREGATES; HYALURONIC ACIDS; LOW FLUID SHEAR STRESS; MICROCARRRIERS; SYNTHETIC EXTRACELLULAR MATRIX; THIOL-DISULFIDE EXCHANGE REACTION;

AGGREGATES; BIOCONVERSION; BIOREACTORS; CELL CULTURE; HYDROGELS; OPTIMIZATION; ORGANIC ACIDS; OSTEOBLASTS; PLANTS (BOTANY); ROTATION; SCAFFOLDS; SHEAR STRESS; STRENGTH OF MATERIALS; TISSUE; TISSUE ENGINEERING;

THREE DIMENSIONAL;

HYALURONIC ACID;

ARTICLE; BIOREACTOR; CELL AGGREGATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYDROGEL; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; MICROCARRIER CULTURE; PRIORITY JOURNAL; TISSUE ENGINEERING; TISSUE REGENERATION;

BIOREACTORS; CELL LINE; CHROMOSOMES; DISULFIDES; EPITHELIAL CELLS; HUMANS; HYALURONIC ACID; HYDROGEL; SULFHYDRYL COMPOUNDS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77956185956     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.07.047     Document Type: Article

References (64)

1. Lavik E., Langer R. Tissue engineering: current state and perspectives. Appl Microbiol Biotechnol 2004, 65:1-8.
2. Ifkovits J.L., Burdick J.A. Review: photopolymerizable and degradable biomaterials for tissue engineering applications. Tissue Eng 2007, 13:2369-2385.
3. Prestwich G.D., Shu X.Z., Liu Y., Cai S., Walsh J.F., Hughes C.W., et al. Injectable synthetic extracellular matrices for tissue engineering and repair. Adv Exp Med Biol 2006, 585:125-133.
4. Prestwich G.D. Biomaterials from chemically modified hyaluronan. Glycoforum 2010, Online. http://www.glycoforum.gr.jp/science/hyaluronan/HA18/HA18E.html.
5. Shu X.Z., Liu Y., Palumbo F.S., Luo Y., Prestwich G.D. In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials 2004, 25:1339-1348.
6. Prestwich G.D. Simplifying the extracellular matrix for 3-D cell culture and tissue engineering: a pragmatic approach. J Cell Biochem 2007, 101:1370-1383.
7. Prestwich G.D. Engineering a clinically-useful matrix for cell therapy. Organogenesis 2008, 4:42-47.
8. Liu Y., Cai S., Shu X.Z., Shelby J., Prestwich G.D. Release of basic fibroblast growth factor from a crosslinked glycosaminoglycan hydrogel promotes wound healing. Wound Repair Regen 2007, 15:245-251.
9. Orlandi R.R., Shu X.Z., McGill L., Petersen E., Prestwich G.D. Structural variations in a single hyaluronan derivative significantly alter wound-healing effects in the rabbit maxillary sinus. Laryngoscope 2007, 117:1288-1295.
10. Liu Y., Shu X.Z., Prestwich G.D. Reduced postoperative intra-abdominal adhesions using Carbylan-SX, a semisynthetic glycosaminoglycan hydrogel. Fertil Steril 2007, 87:940-948.
11. Liu Y., Skardal A., Shu X.Z., Prestwich G.D. Prevention of peritendinous adhesions using a hyaluronan-derived hydrogel film following partial-thickness flexor tendon injury. J Orthop Res 2008, 26:562-569.
12. Liu Y., Shu X.Z., Prestwich G.D. Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Tissue Eng 2006, 12:3405-3416.
13. Mironov V., Kasyanov V., Markwald R.R., Prestwich G.D. Bioreactor-free tissue engineering: directed tissue assembly by centrifugal casting. Expert Opin Biol Ther 2008, 8:143-152.
14. Kasyanov V.A., Hodde J., Hiles M.C., Eisenberg C., Eisenberg L., De Castro L.E., et al. Rapid biofabrication of tubular tissue constructs by centrifugal casting in a decellularized natural scaffold with laser-machined micropores. J Mater Sci Mater Med 2009, 20:329-337.
15. Liu Y., Shu X.Z., Prestwich G.D. Tumor engineering: orthotopic cancer models in mice using cell-loaded, injectable, cross-linked hyaluronan-derived hydrogels. Tissue Eng 2007, 13:1091-1101.
16. Serban M.A., Scott A., Prestwich G.D. Use of hyaluronan-derived hydrogels for three-dimensional cell culture and tumor xenografts. Curr Protoc Cell Biol 2008, [Chapter 10:Unit 10 4].
17. Navran S. The application of low shear modeled microgravity to 3-D cell biology and tissue engineering. Biotechnol Annu Rev 2008, 14:275-296.
18. Nickerson C.A., Richter E.G., Ott C.M. Studying host-pathogen interactions in 3-D: organotypic models for infectious disease and drug development. J Neuroimmune Pharmacol 2007, 2:26-31.
19. Schwarz R.P., Goodwin T.J., Wolf D.A. Cell culture for three-dimensional modeling in rotating-wall vessels: an application of simulated microgravity. J Tissue Cult Methods 1992, 14:51-57.
20. Unsworth B.R., Lelkes P.I. Growing tissues in microgravity. Nat Med 1998, 4:901-907.
21. Nickerson C.A., Ott C.M. A new dimension in modeling infectious disease. ASM News 2004, 70:169-175.
22. Barrila J, Radtke A, Sarker S, Crabbé A, Herbst-Kralovetz MM, Ott CM, et al. 3-D cell culture models: innovative and predictive platforms for studying human disease pathways and drug design. Nat Rev Microbiol, in press.
23. Yoffe B., Darlington G.J., Soriano H.E., Krishnan B., Risin D., Pellis N.R., et al. Cultures of human liver cells in simulated microgravity environment. Adv Space Res 1999, 24:829-836.
24. Carterson A.J., Honer zu Bentrup K., Ott C.M., Clarke M.S., Pierson D.L., Vanderburg C.R., et al. A549 lung epithelial cells grown as three-dimensional aggregates: alternative tissue culture model for Pseudomonas aeruginosa pathogenesis. Infect Immun 2005, 73:1129-1140.
25. Honer zu Bentrup K., Ramamurthy R., Ott C.M., Emami K., Nelman-Gonzalez M., Wilson J.W., et al. Three-dimensional organotypic models of human colonic epithelium to study the early stages of enteric salmonellosis. Microbes Infect 2006, 8:1813-1825.
26. Nickerson C.A., Goodwin T.J., Terlonge J., Ott C.M., Buchanan K.L., Uicker W.C., et al. Three-dimensional tissue assemblies: novel models for the study of Salmonella enterica serovar Typhimurium pathogenesis. Infect Immun 2001, 69:7106-7120.
27. Sainz B., TenCate V., Uprichard S.L. Three-dimensional Huh7 cell culture system for the study of Hepatitis C virus infection. Virol J 2009, 6:103.
28. Smith Y.C., Grande K.K., Rasmussen S.B., O'Brien A.D. Novel three-dimensional organoid model for evaluation of the interaction of uropathogenic Escherichia coli with terminally differentiated human urothelial cells. Infect Immun 2006, 74:750-757.
29. Myers T.A., Nickerson C.A., Kaushal D., Ott C.M., Honer zu Bentrup K., Ramamurthy R., et al. Closing the phenotypic gap between transformed neuronal cell lines in culture and untransformed neurons. J Neurosci Methods 2008, 174:31-41.
30. Hjelm B.E., Berta A.N., Nickerson C.A., Arntzen C.J., Herbst-Kralovetz M.M. Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model. Biol Reprod 2010, 82:617-627.
31. Bursac N., Loo Y., Leong K., Tung L. Novel anisotropic engineered cardiac tissues: studies of electrical propagation. Biochem Biophys Res Commun 2007, 361:847-853.
32. Frye C.A., Patrick C.W. Three-dimensional adipose tissue model using low shear bioreactors. In Vitro Cell Dev Biol Anim 2006, 42:109-114.
33. Yoshioka T., Mishima H., Ohyabu Y., Sakai S., Akaogi H., Ishii T., et al. Repair of large osteochondral defects with allogeneic cartilaginous aggregates formed from bone marrow-derived cells using RWV bioreactor. J Orthop Res 2007, 25:1291-1298.
34. LaMarca H.L., Ott C.M., Honer Zu Bentrup K., Leblanc C.L., Pierson D.L., Nelson A.B., et al. Three-dimensional growth of extravillous cytotrophoblasts promotes differentiation and invasion. Placenta 2005, 26:709-720.
35. Baker T.L., Goodwin T.J. Three-dimensional culture of bovine chondrocytes in rotating-wall vessels. In Vitro Cell Dev Biol Anim 1997, 33:358-365.
36. Duke P.J., Daane E.L., Montufar-Solis D. Studies of chondrogenesis in rotating systems. J Cell Biochem 1993, 51:274-282.
37. Becker J.L., Blanchard D.K. Characterization of primary breast carcinomas grown in three-dimensional cultures. J Surg Res 2007, 142:256-262.
38. Gerecht-Nir S., Cohen S., Itskovitz-Eldor J. Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol Bioeng 2004, 86:493-502.
39. Yamada K.M., Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007, 130:601-610.
40. Griffith L.G., Swartz M.A. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 2006, 7:211-224.
41. Kabelitz D., Medzhitov R. Innate immunity-cross-talk with adaptive immunity through pattern recognition receptors and cytokines. Curr Opin Immunol 2007, 19:1-3.
42. Straub T.M., Honer zu Bentrup K., Orosz-Coghlan P., Dohnalkova A., Mayer B.K., Bartholomew R.A., et al. In vitro cell culture infectivity assay for human noroviruses. Emerg Infect Dis 2007, 13:396-403.
43. Guo X.M., Zhao Y.S., Chang H.X., Wang C.Y., E L.L., Zhang X.A., et al. Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation 2006, 113:2229-2237.
44. Rutzky L.P., Bilinski S., Kloc M., Phan T., Zhang H., Katz S.M., et al. Microgravity culture condition reduces immunogenicity and improves function of pancreatic islets1. Transplantation 2002, 74:13-21.
45. Stepkowski S.M., Phan T., Zhang H., Bilinski S., Kloc M., Qi Y., et al. Immature syngeneic dendritic cells potentiate tolerance to pancreatic islet allografts depleted of donor dendritic cells in microgravity culture condition. Transplantation 2006, 82:1756-1763.
46. Lacroix M. Persistent use of " false" cell lines. Int J Cancer 2008, 122:1-4.
47. Connors R.C., Muir J.J., Liu Y., Reiss G.R., Kouretas P.C., Whitten M.G., et al. Postoperative pericardial adhesion prevention using Carbylan-SX in a rabbit model. J Surg Res 2007, 140:237-242.
48. Zhang J., Skardal A., Prestwich G.D. Engineered extracellular matrices with cleavable crosslinkers for cell expansion and easy cell recovery. Biomaterials 2008, 29:4521-4531.
49. Shu X.Z., Ahmad S., Liu Y., Prestwich G.D. Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering. J Biomed Mater Res A 2006, 79:902-912.
50. Ekaputra A.K., Prestwich G.D., Cool S.M., Hutmacher D.W. Combining electrospun scaffolds with electrosprayed hydrogels leads to three-dimensional cellularization of hybrid constructs. Biomacromolecules 2008, 9:2097-2103.
51. Flynn L., Prestwich G.D., Semple J.L., Woodhouse K.A. Adipose tissue engineering in vivo with adipose-derived stem cells on naturally derived scaffolds. J Biomed Mater Res A 2009, 89:929-941.
52. Ghosh K., Ren X.D., Shu X.Z., Prestwich G.D., Clark R.A. Fibronectin functional domains coupled to hyaluronan stimulate adult human dermal fibroblast responses critical for wound healing. Tissue Eng 2006, 12:601-613.
53. Serban M.A., Liu Y., Prestwich G.D. Effects of extracellular matrix analogues on primary human fibroblast behavior. Acta Biomater 2008, 4:67-75.
54. Prestwich G.D., Kuo J.W. Chemically-modified HA for therapy and regenerative medicine. Curr Pharm Biotechnol 2008, 9:242-245.
55. Carvalho H.M., Teel L.D., Goping G., O'Brien A.D. A three-dimensional tissue culture model for the study of attach and efface lesion formation by enteropathogenic and enterohaemorrhagic Escherichia coli. Cell Microbiol 2005, 7:1771-1781.
56. Alix-Panabieres C., Vendrell J.P., Slijper M., Pelle O., Barbotte E., Mercier G., et al. Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer. Breast Cancer Res 2009, 11:R39.
57. Orban E., Szabo E., Lotz G., Kupcsulik P., Paska C., Schaff Z., et al. Different expression of occludin and ZO-1 in primary and metastatic liver tumors. Pathol Oncol Res 2008, 14:299-306.
58. Burdick J.A., Vunjak-Novakovic G. Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A 2009, 15:205-219.
59. Gerecht S., Burdick J.A., Ferreira L.S., Townsend S.A., Langer R., Vunjak-Novakovic G. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A 2007, 104:11298-11303.
60. Turner W.S., Seagle C., Galanko J.A., Favorov O., Prestwich G.D., Macdonald J.M., et al. Nuclear magnetic resonance metabolomic footprinting of human hepatic stem cells and hepatoblasts cultured in hyaluronan-matrix hydrogels. Stem Cells 2008, 26:1547-1555.
61. Draper J.S., Smith K., Gokhale P., Moore H.D., Maltby E., Johnson J., et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 2004, 22:53-54.
62. Mitalipova M.M., Rao R.R., Hoyer D.M., Johnson J.A., Meisner L.F., Jones K.L., et al. Preserving the genetic integrity of human embryonic stem cells. Nat Biotechnol 2005, 23:19-20.
63. Mironov V., Visconti R.P., Kasyanov V., Forgacs G., Drake C.J., Markwald R.R. Organ printing: tissue spheroids as building blocks. Biomaterials 2009, 30:2164-2174.
64. Norotte C., Marga F.S., Niklason L.E., Forgacs G. Scaffold-free vascular tissue engineering using bioprinting. Biomaterials 2009, 30:5910-5917.